Cargando…

Post-antibiotic effect of orbifloxacin against Escherichia coli and Pseudomonas aeruginosa isolates from dogs

Orbifloxacin is a fluoroquinolone drug used widely in companion animal medicine. In this study, we firstly determined post-antibiotic effects (PAEs) and post-antibiotic sub-minimum inhibitory concentrations (MIC) effects (PA-SMEs) of orbifloxacin for two strains each of Escherichia coli and Pseudomo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harada, Kazuki, Shimizu, Takae, Kataoka, Yasushi, Takahashi, Toshio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338406/ https://www.ncbi.nlm.nih.gov/pubmed/22433170 http://dx.doi.org/10.1186/1751-0147-54-16

Ejemplares similares

Mutant prevention concentration of orbifloxacin: comparison between Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus pseudintermedius of canine origin
por: Shimizu, Takae, et al.
Publicado: (2013)

Effects of oral orbifloxacin on fecal coliforms in healthy cats: a pilot study
por: HARADA, Kazuki, et al.
Publicado: (2015)

Clonal spread of antimicrobial-resistant Escherichia coli isolates among pups in two kennels
por: Harada, Kazuki, et al.
Publicado: (2011)

A pharmacodynamic investigation to assess the synergism of orbifloxacin and propyl gallate against Escherichia coli
por: Abbas, Muhammad Aleem, et al.
Publicado: (2022)

Application of Enrofloxacin and Orbifloxacin Disks Approved in Japan for Susceptibility Testing of Representative Veterinary Respiratory Pathogens
por: HARADA, Kazuki, et al.
Publicado: (2014)

Ecthyma Gangrenosum: Escherichia coli or Pseudomonas aeruginosa?
por: Abbas, Mohamed, et al.
Publicado: (2017)

Assessment of urinary pharmacokinetic and pharmacodynamic profiles of faropenem against extended-spectrum β-lactamase-producing Escherichia coli with canine ex vivo modelling: a pilot study
por: Harada, Kazuki, et al.
Publicado: (2019)

Biomolecular Mechanisms of Pseudomonas aeruginosa and Escherichia coli Biofilm Formation
por: Laverty, Garry, et al.
Publicado: (2014)

The behaviour of Escherichia coli and Pseudomonas aeruginosa in bottled mineral water
por: Schalli, Michael, et al.
Publicado: (2023)

Scaffold size-dependent effect on the enhanced uptake of antibiotics and other compounds by Escherichia coli and Pseudomonas aeruginosa
por: Yamamoto, Kyosuke, et al.
Publicado: (2022)

Structure, Solubility and Stability of Orbifloxacin Crystal Forms: Hemihydrate versus Anhydrate
por: Santos, Olimpia Maria Martins, et al.
Publicado: (2016)

Urinary Pharmacokinetic and Pharmacodynamic Profiles of Fosfomycin against Extended-Spectrum β-Lactamase-Producing Escherichia coli with Canine Ex Vivo Modeling: A Pilot Study
por: Harada, Kazuki, et al.
Publicado: (2020)

Antimicrobial Susceptibility of Enterococcal Species Isolated from Antibiotic-Treated Dogs and Cats
por: KATAOKA, Yasushi, et al.
Publicado: (2014)

Evaluations of the Effects of Extremely Low-Frequency Electromagnetic Fields on Growth and Antibiotic Susceptibility of Escherichia coli and Pseudomonas aeruginosa
por: Segatore, B., et al.
Publicado: (2012)

Performance evaluation of ozonation for removal of antibiotic-resistant Escherichia coli and Pseudomonas aeruginosa and genes from hospital wastewater
por: Baghal Asghari, Farzaneh, et al.
Publicado: (2021)

Role of Fly Cleaning Behavior on Carriage of Escherichia coli and Pseudomonas aeruginosa
por: Jacques, B J, et al.
Publicado: (2017)

Antimicrobial Resistance of Escherichia coli and Pseudomonas aeruginosa from Companion Birds
por: Varriale, Lorena, et al.
Publicado: (2020)

Strategies to Tackle Antimicrobial Resistance: The Example of Escherichia coli and Pseudomonas aeruginosa
por: Antonelli, Giada, et al.
Publicado: (2021)

Challenging T > MIC Using Meropenem vs. Escherichia coli and Pseudomonas aeruginosa
por: Nussbaumer-Pröll, A., et al.
Publicado: (2022)

Development and Validation of a Microbiological Agar Assay for Determination of Orbifloxacin in Pharmaceutical Preparation
por: Cazedey, Edith C. L., et al.
Publicado: (2011)

Characteristics of Antibiotic Resistance and Tolerance of Environmentally Endemic Pseudomonas aeruginosa
por: Kim, Seryoung, et al.
Publicado: (2022)

Antibiotic Susceptibilities of Pseudomonas aeruginosa Isolated from Blood Samples and Antibiotic Utilization in a University Hospital in Japan
por: Kato, Ito, et al.
Publicado: (2015)

Pseudomonas aeruginosa Promotes Escherichia coli Biofilm Formation in Nutrient-Limited Medium
por: Culotti, Alessandro, et al.
Publicado: (2014)

Human Target Attainment Probabilities for Delafloxacin against Escherichia coli and Pseudomonas aeruginosa
por: Hoover, Randall, et al.
Publicado: (2017)

Characterization of Antimicrobial Resistance in Serratia spp. and Citrobacter spp. Isolates from Companion Animals in Japan: Nosocomial Dissemination of Extended-Spectrum Cephalosporin-Resistant Citrobacter freundii
por: Harada, Kazuki, et al.
Publicado: (2019)

First case of Propionibacterium acnes urinary tract infection in a dog
por: Harada, Kazuki, et al.
Publicado: (2015)

Establishing Quality Control Ranges for Antimicrobial Susceptibility Testing of Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus: A Cornerstone to Develop Reference Strains for Korean Clinical Microbiology Laboratories
por: Hong, Sung Kuk, et al.
Publicado: (2015)

The Escherichia coli transcriptome linked to growth fitness
por: Ying, Bei-Wen, et al.
Publicado: (2015)

Lack of Change in Susceptibility of Pseudomonas aeruginosa in a Pediatric Hospital Despite Marked Changes in Antibiotic Utilization
por: Bosso, John A.
Publicado: (2014)

Escherichia coli BdcA controls biofilm dispersal in Pseudomonas aeruginosa and Rhizobium meliloti
por: Ma, Qun, et al.
Publicado: (2011)

Synergistic Activity of Fosfomycin, Ciprofloxacin, and Gentamicin Against Escherichia coli and Pseudomonas aeruginosa Biofilms
por: Wang, Lei, et al.
Publicado: (2019)

Escherichia coli Nissle 1917 inhibits biofilm formation and mitigates virulence in Pseudomonas aeruginosa
por: Aljohani, Ahmad M., et al.
Publicado: (2023)

The efficacy of immediate versus delayed antibiotic administration on bacterial growth and biofilm production of selected strains of uropathogenic Escherichia coli and Pseudomonas aeruginosa
por: Gandee, Leah, et al.
Publicado: (2015)

In Vitro Activity of Rifabutin and Rifampin against Antibiotic-Resistant Acinetobacter baumannii, Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Klebsiella pneumoniae
por: Lee, Bosul, et al.
Publicado: (2021)

Penetration through Outer Membrane and Efflux Potential in Pseudomonas aeruginosa of Bulgecin A as an Adjuvant to β-Lactam Antibiotics
por: Kim, Choon, et al.
Publicado: (2023)

Pseudomonas aeruginosa endophthalmitis masquerading as chronic uveitis
por: Nagaraj, Kalpana Badami, et al.
Publicado: (2013)

Phylogenetic groups and cephalosporin resistance genes of Escherichia coli from diseased food-producing animals in Japan
por: Asai, Tetsuo, et al.
Publicado: (2011)

Successful use of intravitreal and systemic colistin in treating multidrug resistant Pseudomonas aeruginosa post-operative endophthalmitis
por: Samant, Preetam, et al.
Publicado: (2014)

Effect of Bacteriophage Infection in Combination with Tobramycin on the Emergence of Resistance in Escherichia coli and Pseudomonas aeruginosa Biofilms
por: Coulter, Lindsey B., et al.
Publicado: (2014)

Contamination of Hospital Water Supplies in Gilan, Iran, with Legionella pneumophila, Escherichia coli, and Pseudomonas aeruginosa
por: Ahmadi Jalali Moghadam, Masoumeh, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jljd4edqasln2sdd7v9p2i9d98